Recent study has shown that CXCL3 overexpression can promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway40, and can be a potential therapeutic target for breast cancer41. The gene discussed is CXCL3; the disease is cervical cancer.